01942.HK
MOG Holdings Limited
HKSE · Healthcare · Medical - Instruments & Supplies · MY
HKD 0.08
+1.30%Income statement
| Metric | TTM | 2022 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Revenue | |||||
| Total Revenue | 444.5M | 467.0M | 349.5M | 99.2M | 147.1M |
| Cost of Revenue | 320.9M | 336.6M | 243.1M | 30.4M | 49.8M |
| Gross Profit | 123.6M | 130.4M | 106.4M | 68.8M | 97.3M |
| Operating Expenses | |||||
| R&D Expense | — | — | — | — | — |
| SG&A Expense | 71.8M | 149.8M | 92.5M | 94.5M | 67.7M |
| General & Admin Expense | (5.8M) | 69.3M | 19.2M | 19.6M | 10.5M |
| Selling & Marketing Expense | 78.6M | 75.8M | 73.3M | 74.8M | 51.4M |
| Other Expenses | 1.3M | — | (2.8M) | (36.5M) | — |
| Total Operating Expenses | 77.2M | 149.8M | 89.7M | 58.0M | 67.7M |
| Cost and Expenses | 398.1M | 486.3M | 332.1M | 88.4M | 117.5M |
| Operating Income (EBIT) | 47.8M | (26.1M) | 16.8M | 10.9M | 29.6M |
| Non-Operating | |||||
| Interest Income | 789.5K | 968.7K | 2.5M | — | — |
| Interest Expense | 276.0K | 1.2M | 937.1K | 501.0K | 862.0K |
| Net Interest Income | 513.5K | 968.7K | 1.6M | (501.0K) | (862.0K) |
| Other Non-Op Income/Expense | 9.2M | 4.3M | 9.6M | 6.6M | (8.8M) |
| Non-Operating Income (excl Interest) | (1.07) | (18.7K) | (10.6M) | — | — |
| EBT (Pre-Tax Income) | 57.0M | (21.8M) | 26.4M | 17.5M | 20.8M |
| Income Tax Expense | 6.1M | 8.0M | 7.5M | 5.2M | 7.0M |
| Bottom Line | |||||
| Net Income | 47.9M | (23.7M) | 15.3M | 9.9M | 10.9M |
| Earnings from Cont. Ops | — | (19.9M) | 18.9M | 12.3M | — |
| Earnings from Discont. Ops | — | — | — | — | — |
| Bottom Line Net Income | 47.9M | (23.7M) | 15.3M | 9.9M | 10.9M |
| Per Share | |||||
| Basic EPS | HK$0.10 | (HK$0.04) | HK$0.03 | HK$0.02 | HK$0.03 |
| Diluted EPS | HK$0.10 | (HK$0.04) | HK$0.03 | HK$0.02 | HK$0.03 |
| Revenue Per Share | HK$0.74 | HK$0.86 | HK$0.70 | HK$0.20 | HK$0.29 |
| Shares | |||||
| Basic Shares Outstanding | 599.3M | 542.1M | 500.0M | 495.2M | 500.0M |
| Diluted Shares Outstanding | 599.3M | 542.1M | 500.0M | 495.2M | 500.0M |
| Profitability Metrics | |||||
| EBITDA | 58.4M | (14.3M) | 48.7M | 13.9M | 32.5M |
| D&A | 10.6M | 5.0M | 21.3M | 3.0M | 2.9M |
| EBIT | 47.8M | (19.3M) | 27.4M | 10.9M | 29.6M |
As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Dec 1, 2022